ESEvgenii I Sas

Evgenii I Sas

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Evgenii I Sas has a total of 127 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Gastrointestinal disorders in post-COVID syndrome. Clinical guidelines

    by V. B. Grinevich, L. B. Lazebnik, Yu. A. Kravchuk, V. G. Radchenko, E. I. Tkachenko, A. M. Pershko, P. V. Seliverstov, C. P. Salikova, K. V. Zhdanov, K. V. Kozlov, et al.

    Summary Post- COVID syndrome refers to the long-term consequences of a new coronavirus infection COVID-19, which includes a set of symptoms that develop or persist after COVID-19. Symptoms of gastrointestinal disorders in post- COVID syndrome, due to chronic infl ammation, the consequences of organ damage, prolonged hospitalization, social isolation, and other causes, can be persistent and require a multidisciplinary approach. The presented clinical practice guidelines consider the main preventive and therapeutic and diagnostic approaches to the management of patients with gastroenterological manifestations of postCOVID syndrome. The Guidelines were approved by the 17th National Congress of Internal Medicine and the 25th Congress of Gastroenterological Scientifi c Society of Russia.


  • Open Access

    Management of patients with digestive diseases during the COVID-19 pandemic. Clinical Practice Guidelines by the Russian scientific medical society of internal medicine (RSMSIM) and the Gastroenterological Scientific Society of Russia (2nd edition)

    by V. B. Grinevich, Yu. A. Kravchuk, В. И. Педь, E. I. Sas, S. P. Salikova, I. V. Gubonina, E. I. Tkachenko, S. I. Sitkin, L. B. Lazebnik, E. V. Golovanova, et al.

    The presented clinical practice guidelines of the Gastroenterological Scientific Society of Russia (GSSR), diagnostic, and therapeutic approaches for patients with digestive diseases during the COVID-19 pandemic. The guidelines were approved by the XXIII Congress of the GSSR and the 22nd International Slavonic-Baltic Scientifi c Forum “St. Petersburg - Gastro-2020 ON-LINE” (St. Petersburg, June 11, 2020). The presented clinical practice guidelines of the Russian Scientific Medical Society of Internal Medicine (RSMSIM) and the Gastroenterological Scientific Society of Russia (GSSR), diagnostic, and therapeutic approaches for patients with digestive diseases during the COVID-19 pandemic. The recommendations were approved at the XV National Congress of Internal Medicine, XXIII Congress of NOGR on the basis of the 1st edition, adopted at the 22nd International Slavic- Baltic Scientific Forum “St. Petersburg - Gastro-2020 ON-LINE”.


  • Open Access

    Resolution of the expert council “Relevant issues of iron deficiency in the Russian Federation”

    by O. M. Drapkina, A. I. Martynov, A. P. Baida, V. E. Balan, I. I. Baranov, E. E. Vlasova, P. A. Vorobiev, S. A. Volkova, I. Yu. Gaiduk, Zh. A. Gornostaeva, et al.

    Резолюция экспертного совета “Актуальные вопросы железодефицита в Российской Федерации”


  • Open Access

    The role of sarcopenia in the development of non-alcoholic fatty liver disease

    by V. B. Grinevich, E. I. Sas

    Currently, a large number of studies have been published supplementing our knowledge of sarcopenia and its effect on the development of metabolic disorders, including the formation of NAFLD. This data allows a new look at the pharmacological and non-pharmacological approaches to the treatment of NAFLD, based on basic physiological processes, including the biological axis of the muscle — the liver. This provides a compelling rationale for studying skeletal muscle as the main therapeutic target for NAFLD and metabolic syndrome.


  • Open Access

    Fecal transplantation: clinical realities and prospects in the treatment of metabolic syndrome

    by E. I. Sas, V. B. Grinevich, V. A. Barnakova

    The review provides an analysis of the available data on the clinical efficacy of fecal transplantation in various diseases. Promising areas of this type of therapy are identified, as well as unresolved issues regarding both the methodology itself and the evaluation of effectiveness.


  • Open Access

    The evolution of the concept of the intestinal microbial-tissue complex

    by V. B. Grinevich, Yu. A. Kravchuk, E. I. Sas

    The human gastrointestinal tract is one of the largest in area — points of contact between the internal environment of the host and environmental factors.The most important functional element of this interaction is the microbial — tissue complex of the gastrointestinal tract, and its permeability is defined as a key option in the implementation of the mechanisms of adaptation and homeostasis.The microbiota is represented in various interpretations by the main four domains (archaea, bacteria or eubacteria, eukaryotes and viruses). The combination of these domains into the Biota taxon suggests the need to use the term biota-tissue complex, which more fully reflects the sophisticated interactions of all microbial-tissue complexes of the body.


  • Open Access

    Management of patients with comorbidity during novel coronavirus (COVID-19) pandemic. National Consensus Statement 2020

    by V. B. Grinevich, I. V. Gubonina, V. L. Doshchitsin, Yu. V. Kotovskaya, Yu. A. Kravchuk, В. И. Педь, E. I. Sas, A. V. Syrov, A. V. Tarasov, A. I. Tarzimanova, et al.

    The pandemic of the novel coronavirus infection (COVID-19), caused by SARS‑CoV‑2, has become a challenge to healthcare systems in all countries of the world. Patients with comorbidity are the most vulnerable group with the high risk of adverse outcomes. The problem of managing these patients in context of a pandemic requires a comprehensive approach aimed both at the optimal management in self-isolated patients not visiting medical facilities, and management of comorbidities in patients with COVID-19. The presented consensus covers these two aspects of managing patients with cardiovascular disease, diabetes, chronic obstructive pulmonary disease, gastrointestinal disease, and also pay attention to the multiple organ complications of COVID-19.


  • Open Access

    Difficult patient. Management of resistant constipation

    by E. I. Sas, V. В. Grinevich

    Just like the vast majority of diseases, constipation is now associated with civilization and urbanization. According to epidemiological data, up to 30% of the adult population of economically developed countries suffer from this nosology, among which women predominate. It is known that only one of four patients suffering from stool retention visit a specialist. The rest confine themselves to the advice of friends, reading of popular medical literature or consulting a pharmacist at the pharmacy. Thus, only 25% of our patients receive medical care (we cannot talk about quality, nevertheless, the care is medical), and 75%, as a rule, only periodically try to set off this condition. Constipation is dangerous as it may cause the development of complications: secondary colitis, proctosigmoiditis, hemorrhoids, anal fissures, paraproctitis and the most threatening disease – colorectal cancer. Therapy for constipation should first begin with lifestyle changes. The irritating agents that enhance secretion are the drugs that are most frequently used, because they very quickly and reliably achieve the effect. Thus, among the most commonly used and effective ones are sodium picosulfate (Regulax®) preparations.


  • Open Access

    Human gut microbiota community structures in urban and rural populations in Russia

    by Alexander V Tyakht, Elena S Kostryukova, Anna S Popenko, Maxim S Belenikin, Alexander V Pavlenko, Andrey K Larin, Irina Y Karpova, Oksana V Selezneva, Tatyana A Semashko, Elena A Ospanova, et al.

    The microbial community of the human gut has a crucial role in sustaining host homeostasis. High-throughput DNA sequencing has delineated the structural and functional configurations of gut metagenomes in world populations. The microbiota of the Russian population is of particular interest to researchers, because Russia encompasses a uniquely wide range of environmental conditions and ethnogeographical cohorts. Here we conduct a shotgun metagenomic analysis of gut microbiota samples from 96 healthy Russian adult subjects, which reveals novel microbial community structures. The communities from several rural regions display similarities within each region and are dominated by the bacterial taxa associated with the healthy gut. Functional analysis shows that the metabolic pathways exhibiting differential abundance in the novel types are primarily associated with the trade-off between the Bacteroidetes and Firmicutes phyla. The specific signatures of the Russian gut microbiota are likely linked to the host diet, cultural habits and socioeconomic status.


    • 1 January 2011
      • No. 7,p. 13-7

    [Chronic pancreatitis: microbe-intestinal tissue complex and systemic inflammatory response].

    by V B Grinevich, E I Sas, N L Denisov, O I Efimov

    Today in Russian Federation, we observe significant growth of the chronic pancreatitis incidence with the depression of its therapy efficiency (more than 20% of the patients) and complications rate growth. In many respects given tendency is associated with the inefficiency of traditional medications combination in the context of inflammation process reduction, gut dysbiosis correction and chronic inflammation reaction depression. Present-day studies indicates, that the grade and character of inflammation in the pancreas depends on the pro- and anti-inflammatory cytokines balance, which is associated with the elevation of the pathogenic microbiota concentration and permeability of the gut. We estimate clinical efficacy of complex treatment regimen (PPI, spasmolytic, multienzyme and prebiotic therapy) in the patients with chronic pancreatitis and its effect on chronic system inflammation. We established that efficacy of modern complex treatment regimen depends on its influence on chronic system inflammation and that prebiotics addition potentiates correction of dysbiotic changes in the gut microbial-tissular complex and reduces grade of system inflammation.